IGF-1对不同年龄缺血性脑损伤大鼠神经发生的影响

目的:检测胰岛素样生长因子-1(IGF-1)对青年和老年大鼠局灶脑缺血后神经发生及其后细胞生存的影响.方法:健康雄性SD青年鼠(3-4个月)和老年鼠(1年)随机分组,侧脑室注入IGF-1,1天后进行大鼠大脑中动脉阻塞(MCAO),对照组由生理盐水取代.采用BrdU标记方法鉴定MCAO后7d和28d的增殖细胞.BrdU于MCAO后第6d由腹腔注入.免疫组化法检测7天后BrdU、PSA-NCAM标记细胞和28天后BrdU、BrdU/MAP2双标细胞.结果:老年组中BrdU阳性细胞的数目7d后较对照组增加5.1倍;青年纽中BrdU阳性细胞的数目7d后较对照组增加5.5倍.28d后,BrdU阳性细胞的残留率在青年IGF-1处理组和老年IGF-1处理组中分别是79.2%和75.1%,分别相对于对照组的77.1%和52.3%.老年组中PSA-NCAM阳性细胞的数目7d后较对照组增加3.2倍;青年组中PSA-NCAM阳性细胞的数目7d后较对照组增加3.7倍.28d后,BrdU/MAP2阳性细胞在青年IGF-1处理组较对照组增加7.0倍,在老年IGF-1处理组较对照组增加4.9倍.结论:此结果提示局部应用IGF-1进行缺血前预处理,在青年鼠和老年鼠中均能诱导神经发生,且在老年鼠中能明显提高神经发生后的增殖细胞的生存率和向神经元分化的能力.这一研究结果将有助于研究IGF-1在中老年脑损伤病人中的治疗性应用.     

局灶性脑缺血后海马齿状回神经发生及其与血管内皮生长因子关系的研究

目的研究成年大鼠局灶性脑缺血后海马齿状回（DG）神经发生的情况及其与血管内皮生长因子（VEGF）的关系,探讨脑缺血后神经发生及其调控机制。方法通过大脑中动脉阻断法（MCAO）建立大鼠局灶性脑缺血模型,以5-溴-2-脱氧尿核苷（BrdU）标记增殖的神经前体细胞（NPCs）,用免疫组化及免疫荧光双标记法动态检测脑缺血后不同时间DG神经细胞增殖及其分化,同时观察增殖细胞表达VEGF及其受体情况。结果与对照组相比,缺血侧DG的BrdU阳性细胞数在脑缺血后1d开始增加,7d达高峰,28d接近正常水平;BrdU/TuJ1、BrdU/MAP-2阳性双标细胞数在脑缺血后14d开始增加,28d达高峰;BrdU/GFAP阳性双标细胞数则无明显变化;增殖的BrdU阳性细胞同时表达VEGF及其受体FLK-1。结论大鼠局灶性脑缺血可激活DG自体NPCs原位增殖、分化,增殖的细胞同时表达VEGF及其受体可能是脑缺血后神经发生增强的调节机制之一。     

甘珀酸干预对大鼠脑缺血再灌注损伤的影响

目的观察缝隙连接阻断剂甘珀酸对局灶性脑缺血/再灌注损伤的影响。方法采用大鼠大脑中动脉阻塞再灌流模型（MCAO）,将动物随机分为脑缺血60min再灌注（MCAO）组,脑缺血再灌注加甘珀酸干预（MCAO＋CBX）组和假手术组（sham）。采用尼氏染色显示脑梗死灶并计算梗死灶体积;应用免疫荧光与TUNEL染色法分别观察脑缺血后3d与7d不同时间点缺血边缘区胶质纤维酸性蛋白（GFAP）的表达和细胞凋亡情况。结果（1）缺血后3d、7d MCAO＋CBX组大鼠梗死体积小于MCAO组,3d、7d MCAO＋CBX组大鼠梗死体积较MCAO组分别缩小5%和4.6%;（2）缺血后3d、7d于缺血边缘区可见大量TUNEL阳性染色细胞,且MCAO组大鼠缺血边缘区细胞凋亡数目明显多于MCAO＋CBX大鼠（P〈0.001）;（3）缺血后3d和7d组缺血边缘区GFAP表达明显增强,3d的MCAO组与MCAO＋CBX组大鼠缺血边缘区GFAP的表达均较假手术组强（P〈0.05）,7d的MCAO＋CBX组大鼠缺血边缘区GFAP的表达较假手术组强（P〈0.001）,但明显弱于MCAO组大鼠（P〈0.01）;结论缝隙连接阻断剂甘珀酸可减少大鼠大脑中动脉阻塞后脑梗死体积,其机制可能与阻断缝隙连接后缺血边缘区神经元凋亡降低有关,星型胶质细胞的反应性变化参与了该过程。     

运动训练对大鼠局灶性脑梗死区周边皮质GFAP、GAP-43表达的影响

目的:观察运动训练对大鼠局灶性脑梗死区周围皮质的胶质纤维酸性蛋白(glial fibrillary acidic protein,GFAF)和生长相关蛋白-43(growth-associated protein,GAP-43)表达的影响.方法:成年健康雄性sD大鼠42只,随机分为3组:运动组,静止组,假手术对照组.运动组造模后给予电动跑台训练,每天30min;静止组造模后置于普通笼中饲养,不予康复训练;假手术对照组仅给予麻醉及头皮切开、缝合.采用光化学方法建立局灶性脑梗死模型,每组大鼠于术后7d,14d,21d处死,应用免疫组化方法观察各组大鼠不同时期梗死灶周围皮质GFAP和GAP-43的表达结果:运动组梗死灶周围皮质GFAP的表达在14d和21d显著高于静止组和假手术对照组.运动组大鼠GAP-43表达在7d为最高,14d后开始下降,但均显著高于静止组和假手术对照组.静止组大鼠GAP-43表达在7d和14d高于假手术对照组.21d时三组大鼠GAP-43表达无明显差异.结论:运动训练能促进梗死灶周围皮质GFAP和GAP-43的表达,促进脑缺血后的突触发生与重建.     

大鼠局灶性脑缺血后缺血边缘区NG_2细胞的表达

目的观察局灶性脑缺血后缺血边缘区海马和皮层NG2细胞的动态表达,探讨其在脑缺血神经损伤与修复过程中所起的作用。方法将大鼠随机分为假手术组(sham)和脑缺血再灌注组,脑缺血再灌注组采用线栓法制备大鼠大脑中动脉阻塞再灌流模型(MCAO),假手术组不插入线栓,采用免疫荧光组织化学法结合共聚焦显微镜成像观察sham组及脑缺血后3d,7d,30d不同时间点缺血边缘区的海马CA1区和皮层区NG2的动态表达情况。结果脑缺血再灌注后缺血边缘区海马和皮层NG2胶质细胞表达增加,缺血后7d最明显。结论脑缺血后缺血边缘区存在NG2细胞的增生和形态变化可能与脑缺血后损伤修复密切相关。     

产前应激对子代大鼠脑缺血/再灌注后星形胶质细胞的影响

目的：探讨产前应激对雄性子代大鼠大脑中动脉缺血/再灌注后星形胶质细胞的影响。方法：SD孕鼠随机分为有产前应激处理（妊娠第15到21天每日3次限制活动）和无产前应激处理,并对其雄性子代大鼠采用线栓法制备大脑中动脉闭塞（MCAO）模型,共分为产前应激+假手术组、MCAO模型组、产前应激+MCAO组（n=10）,于再灌注后第5天检测脑梗死体积,免疫荧光双标染色检测缺血灶边缘区星形胶质细胞形态及促红细胞生成素肝细胞受体A4（EphA4）和胶质纤维酸性蛋白（GFAP）的共表达情况,并采用Western blot检测EphA4、GFAP和神经蛋白聚糖（Neurocan）蛋白表达。结果：产前应激+MCAO组子代大鼠脑梗死体积百分比、EphA4、GFAP和Neurocan蛋白表达均较MCAO组显著增加（P均<0.05）,且GFAP阳性细胞形态学改变及EphA4/GFAP共表达也较MCAO组明显。结论：产前应激可能改变子代大鼠脑缺血/再灌注后星形胶质细胞上EphA4受体的表达,促进星形胶质细胞活化,产生神经蛋白聚糖。     

大鼠脑缺血再灌注损伤后神经元和星形胶质细胞的动态变化及Cyclin D1表达的差异

目的研究大鼠局灶性脑缺血再灌注损伤后神经元和星形胶质细胞表达量的动态演变及各自cyclin D1的表达差异。方法建立大鼠大脑中动脉阻塞（MCAO）再灌注模型,随机分为再灌注后1d组,3d组,7d组,14d组和假手术组,应用流式细胞术检测各组再灌注后不同时间点神经元和星形胶质细胞数量变化及各自cyclin D1的表达。结果缺血侧梗死边缘区皮质星形胶质细胞的表达增加,而神经元的表达下降,与假手术组比较有明显差异（P〈0．05）;神经元和星形胶质细胞中各自cyclin D1的表达在再灌注7d、14d后表达上调,且星形胶质细胞中的cyclinD1增加更明显,与假手术组比较有统计学差异（P〈0．05）。结论大鼠脑缺血再灌注后,缺血侧梗死边缘区皮质星形胶质细胞和神经元的cyclinD1表达均有不同程度的上调,星形胶质细胞的cyclin D1表达上调比神经元的更为显著。     

缺血后适应对局灶性脑缺血/再灌注大鼠caspase-3表达的影响

目的：探讨缺血后适应对大鼠局灶性脑缺血/再灌注损伤后caspase-3表达的影响。方法：大脑中动脉线拴法复制大鼠局灶性脑缺血/再灌注损伤动物模型。将30只雄性SD大鼠随机分为3组（n=10）：假手术组（sham组）、缺血/再灌注（I/R）组和缺血后适应（IP）组。利用原位缺口末端标记法观察神经细胞凋亡的变化。应用Western blot检测大鼠局灶性脑缺血/再灌注损伤后caspase-3蛋白表达水平的变化。结果：大鼠脑缺血/再灌注后凋亡细胞数量和caspase-3蛋白表达水平均显著升高,而缺血后适应组凋亡细胞数量和caspase-3蛋白表达水平均显著低于缺血/再灌注组（P〈0.01）。结论：缺血后适应可抑制大鼠脑缺血/再灌注后细胞凋亡的发生,此作用可能与下调caspase-3蛋白表达有关。     

AMD3100对局灶脑缺血/再灌注大鼠大脑皮质血管再生的影响

目的探讨AMD3100阻断SDF-1/CXCR4轴后,对局灶脑缺血/再灌注大鼠缺血半暗带血管再生的影响。方法将SD大鼠随机分为假手术组(S组)、模型组(IR组)、AMD3100组(IRA组)、生理盐水组(IRN组)。采用线栓法制备大鼠局灶脑缺血/再灌注模型,缺血2h后将IR、IRA和IRN组分为再灌注12h,1、3和7d四个亚组。HE染色观察局灶脑缺血/再灌注后大脑皮质病理变化。免疫组化法检测CD31在缺血半暗带表达。荧光定量PCR检测外周血中AC133mRNA表达。结果与IRN组比较,IRA 12h外周血中AC133mRNA显著升高,第1d升高达峰值(P0.01),IRA 3dAC133mRNA表达比IRA1d显著减少(P0.05);与IRN组比较,IRA组CD31阳性血管密度在第1d无显著变化(P0.05),第3和7d血管密度显著减少(P0.01);IRA 7d梗死区由大量坏死神经细胞和泡沫细胞填充,坏死较严重。结论持续注射AMD3100能动员干/祖细胞快速进入外周血,但可能抑制局灶脑缺血/再灌注大鼠缺血半暗带血管再生,加重梗死区坏死。     

电针对脑缺血再灌注大鼠齿状回Nestin、GFAP表达的影响

目的观察电针对脑缺血再灌注损伤后大鼠齿状回巢蛋白(nestin)及胶质纤维酸性蛋白(GFAP)表达的影响。方法将SD雄性大鼠随机分为假手术组、模型组和电针组,每组再分为3、7、14和21d等4个亚组,每个亚组6只大鼠,采用大脑中动脉线栓法制作脑缺血再灌注模型。电针组选取"百会"、"大椎"穴给予2Hz电针刺激,持续30min,每天1次。采用免疫组织化学染色法显示各组大鼠齿状回nestin及GFAP的表达。结果①模型组nestin的表达在3d、7d、14d时明显高于假手术组(P0.01),21d时和假手术组比较无显著性差异(P0.05);电针组各时间点nestin的表达均显著高于模型组(P0.01或P0.05)。②模型组GFAP的表达在各时间点均明显高于假手术组(P0.01);电针组在7d、14d时GFAP的表达强度明显低于模型组(P0.01或P0.05),但细胞数变化不明显(P0.05),21d时GFAP阳性细胞数及表达强度较模型组均显著降低(P0.01)。结论电针能明显增强急性脑缺血再灌注大鼠齿状回nestin的表达,促进神经再生;并可以下调GFAP的持续过度表达,抑制星型胶质细胞的过度活化和增殖。     

Folic acid stimulates proliferation of transplanted neural stem cells after focal cerebral ischemia in rats

Folic acid (FA) stimulates neural stem cell (NSC) proliferation in vitro and enhances hippocampal neurogenesis in rats after middle cerebral artery occlusion (MCAO). The effect of FA supplementation on exogenous NSCs transplanted in MCAO rats was observed to determine if FA can stimulate NSC replacement after focal cerebral ischemia. Rats were randomly assigned to 3 groups: MCAO; MCAO and exogenous NSC transplantation (MCAO+NSCs); and MCAO, NSC transplantation and FA (MCAO+NSCs+FA). FA (0.8 mg/kg) or vehicle was administered by gavage daily for 28 days before MCAO and 23 days afterward. NSCs were labeled with superparamagnetic iron oxide (SPIO) and bromodeoxyuridine (BrdU) prior to transplantation into the striatum, contralateral to the ischemic zone, at 2 days post-MCAO. Magnetic resonance imaging tracking and fluorescent immunohistochemistry, as well as measurement of serum folate concentration, were performed at intervals up to 21 days after transplantation. FA supplementation caused sustained increases of 400–600% in serum folate concentration. Magnetic resonance images indicated that SPIO-labeled NSCs were more abundant at the transplantation and ischemic brain sites in MCAO+NSCs+FA rats than in MCAO+NSCs rats. Similarly, immunohistochemistry showed that the numbers of Sox-2/BrdU double positive cells at the transplantation and ischemic sites were higher in the rats that received FA. In conclusion, after focal cerebral ischemia, FA supplementation stimulates transplanted NSCs to proliferate and migrate to ischemic sites.     

Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF

Progenitor cells in the dentate gyrus of hippocampus (DG) and the subventricular zone of lateral ventricles (SVZ) generate new neurons throughout the life of mammals. Cerebral ischemia increases this basal progenitor cell proliferation. The present study evaluated the time frame of proliferation, length of survival and the phenotypes of the new cells formed after transient middle cerebral artery occlusion (MCAO) in adult spontaneously hypertensive rats. Compared to sham controls, ischemic rats showed a significantly higher number of newly proliferated cells (as defined by BrdU immunostaining) in both the DG (by fourfold, p < 0.05) and the SVZ (by twofold, p < 0.05). DG showed increased proliferation only in the first week of reperfusion and 49% of the cells formed in this period survived to the end of third week. Whereas, SVZ showed a continuous proliferation up to 3 weeks after MCAO, but the cells formed survived for less than a week. In both DG and SVZ, at the end of the first week of reperfusion, majority of the BrdU-positive (BrdU+) cells were immature neurons (DCX positive). In the DG, 28% of the cells formed in the first week after MCAO mature into neurons (NeuN positive). The ischemic cortex and striatum showed several BrdU+ cells which were ED-1 positive microglia/macrophages. At 1 week of reperfusion, MCAO-induced progenitor cell proliferation in the ipsilateral DG was significantly increased by i.c.v. infusion of IGF-1 (by 127 +/- 14%, p < 0.05) and GDNF (by 91 +/- 5%, p < 0.05), compared to vehicle. In the growth factor treated rats subjected to transient MCAO, several BrdU+ cells formed in the first week survived up to the third week.     

Bone marrow-derived mesenchymal stem cells improve post-ischemia neurological function in rats via the PI3K/AKT/GSK-3β/CRMP-2 pathway

Background: Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) is a potential therapy for cerebral ischemia. However, the underlying protective mechanism remains undetermined. Here, we tested the hypothesis that transplantation of BMSCs via intravenous injection can alleviate neurological functional deficits through activating PI3K/AKT signaling pathway after cerebral ischemia in rats.

Methods: A cerebral ischemic rat model was established by the 2 h middle cerebral artery occlusion (MCAO). Twenty-four hours later, BMSCs (1?×?10⁶ in 1 ml PBS) from SD rats were injected into the tail vein. Neurological function was evaluated by modified neurological severity score (mNSS) and modified adhesive removal test before and on d1, d3, d7, d10 and d14 after MCAO. Protein expressions of AKT, GSK-3β, CRMP-2 and GAP-43 were detected by Western-bolt. NF-200 was detected by immunofluorescence.

Results: BMSCs transplantation did not only significantly improve the mNSS score and the adhesive-removal somatosensory test after MCAO, but also increase the density of NF-200 and the expression of p-AKT, pGSK-3β and GAP-43, while decrease the expression of pCRMP-2. Meanwhile, these effects can be suppressed by LY294002, a specific inhibitor of PI3K/AKT.

Conclusion: These data suggest that transplantation of BMSCs could promote axon growth and neurological deficit recovery after MCAO, which was associated with activation of PI3K/AKT /GSK-3β/CRMP-2 signaling pathway.

     

Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation

The functional benefit of cell transplantation after a myocardial infarction is diminished by early cell losses. IGF-1 enhances cell proliferation and survival. We hypothesized that IGF-1-transfected smooth muscle cells (SMCs) would enhance cell survival and improve engraftment after cell transplantation. The IGF-1 gene was transfected into male SMCs and compared with SMCs transfected with a plasmid vector (vector control) and nontransfected SMCs (cell control). IGF-1 mRNA (n=10/group) and protein levels (n=6/group) were higher (P <0.05 for all groups) at 3, 7, and 14 days compared with controls. VEGF was also increased in parallel to enhanced IGF-1 expression. IGF-1-transfected cells demonstrated greater cell proliferation, stimulated angiogenesis, and decreased caspase-3 activity after simulated ischemia and reperfusion (P <0.05 for all groups compared with vector or cell controls). A uniform left ventricular injury was produced in female rats using a cryoprobe. Three weeks later, 2 x 10(6) cells from three groups were implanted into the scar. One week later, IGF-1-transfected SMCs had increased myocardial IGF-1 and VEGF levels, increased Bcl2 expression, limited cell apoptosis, and enhanced vessel formation in the myocardial scar compared with the two control groups (P <0.05 for all groups). The proportion of SMCs surviving in the implanted region was greater (P <0.05) in the IGF-1-transfected group than in the vector or cell controls. Gene enhancement with IGF-1 improved donor cell proliferation, survival, and engraftment after cell transplantation, perhaps mediated by enhanced angiogenesis and reduced apoptosis.     

Aminoguanidine Administration Ameliorates Hippocampal Damage After Middle Cerebral Artery Occlusion in Rat

The effects of a selective inducible nitric oxide synthase inhibitor aminoguanidine (AG) on neuronal cells survival in hippocampal CA1 region after middle cerebral artery occlusion (MCAO) were examined. Transient focal cerebral ischemia was induced in rats by 60 or 90 min of MCAO, followed by 7 days of reperfusion. AG treatment (150 mg/kg i.p.) significantly reduced total infarct volumes: by 70% after 90 min MCAO and by 95% after 60 min MCAO, compared with saline-treated ischemic group. The number of degenerating neurons in hippocampal CA1 region was also markedly lower in aminoguanidine-treated ischemic groups compared to ischemic groups without AG-treatment. The number of iNOS-positive cells significantly increased in the hippocampal CA1 region of ischemic animals, whereas it was reduced in AG-treated rats. Our findings demonstrate that aminoguanidine decreases ischemic brain damage and improves neurological recovery after transient focal ischemia induced by MCAO.     

IGF1在脑缺血大鼠脑组织中的表达与通络救脑注射液的脑保护作用

目的:观察脑缺血模型大鼠血清及脑组织中IGF1蛋白表达水平,以及通络救脑注射液对该因子表达水平的影响,分析通络救脑注射液的脑保护作用途径。方法:以线栓法制作大鼠大脑中动脉缺血模型(MCAO),将SD大鼠随机分为空白对照组、模型组及通络救脑注射药组,分别在造模后12小时、24小时、3天、7天4个时间点采取动物血清和脑组织,以免疫组化、酶联免疫(ELISA)以及RTPCR的方法,分别检测IGF1的表达部位及定量检测该因子的蛋白及mRNA表达水平,并测定血清NSE含量。结果:IGF1在正常脑组织有表达,在脑缺血后24小时表达增多,此后随脑缺血时间的延长不断减少;通络救脑组IGF1各时间点表达均高于模型组。模型组血清NSE水平显著升高,各时间点与正常组均有显著差异,通络救脑注射液组血清NSE水平在12小时、1天和7天时显著低于模型组。结论:大鼠脑缺血损伤后IGF1表达减少与神经元的坏死有相关性,通络救脑注射液能够提高其表达水平,对缺血损伤的脑组织发挥保护作用。     

大鼠局灶性脑缺血再灌注损伤后纹状体和海马区瞬时受体电位通道蛋白4的表达增加

实验在大鼠大脑中动脉阻塞性脑缺血(middle cerebral arterv occlusion,MCAO)模型上采用Western Blot方法检测脑缺血再灌注不同时程(6h、12h、1d、3d)脑组织中瞬时受体电位通道蛋白4(transient receptor potential channel4,TRPC4)的表达情况,并与正常对照组相比,结果显示,12 h、1 d、3 d组纹状体、海马区域TRPC4含量明显高于正常组(P<0.05)。采用免疫组织化学定位检测,显示TRPC4主要表达在神经元细胞膜上;免疫组化阳性细胞统计分析显示,在不同时程缺血组中纹状体、海马区域TRPC4的表达与正常组相比有所增加,其中纹状体、海马区缺血再灌注1 d、3 d组缺血同侧1RPC4阳性细胞升高显著(P<0.05)。脑缺血再灌注损伤后TRPC4相对含量增加,提示TRPC4可能参与脑缺血引起的急性和迟发性神经元损伤。